🔇 Silence detected
Q4 FY26
Aarti Drugs Limited
Management stopped discussing '15-20% revenue growth aspiration for FY27' — last mentioned in Q3 FY26.
Recent Alerts
Automated signals from management behavior changes across 917 tracked companies.
50 most recent platform alerts
Quarter dashboard
🔇 Silence detected
Q4 FY26
Aarti Drugs Limited
Management stopped discussing 'Capex of ₹150-200 crore per year for next two years' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aarti Drugs Limited
Management stopped discussing 'Domestic antibiotic demand weakness' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aarti Pharmalabs Limited
Management stopped discussing 'Atali greenfield plant commercial production by end of Q2 FY26' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aarti Pharmalabs Limited
Management stopped discussing 'CDMO revenue guidance for FY26 maintained' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aarti Pharmalabs Limited
Management stopped discussing 'Standalone EBITDA growth of 12-15% for FY26' — last mentioned in Q3 FY26.
• Watchlist alert
Q4 FY26
Aavas Financiers Limited
Credibility score dropped from 67% to 0% — missed 1 out of 1 promises.
🔇 Silence detected
Q4 FY26
ABB India Ltd
Management stopped discussing 'Chinese competition in process automation' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
ABB India Ltd
Management stopped discussing 'Double-digit revenue growth ambition' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Enterprises Limited
Management stopped discussing '6 GW solar cell/module line commissioning by September 2026' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Enterprises Limited
Management stopped discussing 'Delayed ramp-up of new assets' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Adani Enterprises Limited
Management stopped discussing 'Electrolyzer testing delays green hydrogen CapEx' — last mentioned in Q1 FY26.
🔇 Silence detected
Q4 FY26
Adani Enterprises Limited
Management stopped discussing 'Navi Mumbai Airport commercial launch in April 2025' — last mentioned in Q1 FY26.
🔇 Silence detected
Q4 FY26
Adani Green Energy Limited
Management stopped discussing 'CapEx of INR 30,000-35,000 crore annually for next 2 years' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Green Energy Limited
Management stopped discussing 'Run-rate EBITDA of INR 16,000 crore post 6 GW addition' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Ports and Special Economic Zone Ltd
Management stopped discussing 'Capex guidance of INR 10,500-11,500 crore for FY25' — last mentioned in Q4 FY25.
🔇 Silence detected
Q4 FY26
Adani Ports and Special Economic Zone Ltd
Management stopped discussing 'Coal volume decline impacting margins at Gangavaram and Krishnapatnam' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Adani Ports and Special Economic Zone Ltd
Management stopped discussing 'FY2026 EBITDA guidance of INR 22,000 crore maintained' — last mentioned in Q1 FY26.
🔇 Silence detected
Q4 FY26
Adani Ports and Special Economic Zone Ltd
Management stopped discussing 'FY25 cargo volume guidance maintained at 460-480 MMT' — last mentioned in Q2 FY25.
🔇 Silence detected
Q4 FY26
Adani Ports and Special Economic Zone Ltd
Management stopped discussing 'FY25 EBITDA guidance upgraded to ₹18,800-18,900 crore' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Adani Power Ltd
Management stopped discussing '80% PPA tie-up for new capacity' — last mentioned in Q2 FY25.
🔇 Silence detected
Q4 FY26
Adani Power Ltd
Management stopped discussing 'Bangladesh payment reconciliation' — last mentioned in Q3 FY25.
🔇 Silence detected
Q4 FY26
Adani Power Ltd
Management stopped discussing 'Capacity expansion target of 12,520 MW by 2030' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Power Ltd
Management stopped discussing 'Execution risk on 23.5 GW expansion' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Adani Power Ltd
Management stopped discussing 'Godda plant receivables and Bangladesh PPA risk' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Total Gas Limited
Management stopped discussing 'CapEx of INR 900-1,000 crore for FY26' — last mentioned in Q1 FY26.
🔇 Silence detected
Q4 FY26
Adani Total Gas Limited
Management stopped discussing 'Declining APM and NWG gas allocation' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Total Gas Limited
Management stopped discussing 'Double-digit volume growth expected to continue' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Adani Total Gas Limited
Management stopped discussing 'EV charging points target of 3,000 by March-April 2025' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Adani Total Gas Limited
Management stopped discussing 'Margin compression from higher gas costs' — last mentioned in Q4 FY25.
🔇 Silence detected
Q4 FY26
Aditya Birla Capital Limited
Management stopped discussing 'Health insurance combined ratio below 100% at earliest' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Aditya Birla Capital Limited
Management stopped discussing 'Impact of surrender value regulations on life insurance margins' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aditya Birla Capital Limited
Management stopped discussing 'Life insurance net VNB margin to expand to 18%+ for FY26' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Aditya Birla Capital Limited
Management stopped discussing 'Margin compression from product mix shift in NBFC' — last mentioned in Q1 FY26.
🔇 Silence detected
Q4 FY26
Aditya Birla Capital Limited
Management stopped discussing 'NBFC portfolio to grow at 25% CAGR over 2-3 years' — last mentioned in Q4 FY25.
🔇 Silence detected
Q4 FY26
Aditya Birla Fashion and Retail Limited
Management stopped discussing 'TCNS to become profitable growth driver by next year' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aditya Birla Fashion and Retail Limited
Management stopped discussing 'Tomorrow to break even by FY29' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Aegis Logistics Limited
Management stopped discussing 'KGPL/JLPL pipeline commissioning in Q2 FY26' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Affle 3i Ltd
Management stopped discussing 'EBITDA growth to outpace revenue' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Limited
Management stopped discussing 'Africa business to achieve double-digit growth in FY26' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Limited
Management stopped discussing 'Forex volatility impacting reported margins' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Limited
Management stopped discussing 'FY26 ANDA Filings: 10-12 filings' — last mentioned in Q4 FY25.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Limited
Management stopped discussing 'Unpredictable institutional business in Africa' — last mentioned in Q4 FY25.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Limited
Management stopped discussing 'US generics run-rate to sustain at current level for FY26' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Ltd
Management stopped discussing 'Capex guidance of ₹300 crore for FY26' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Ajanta Pharma Ltd
Management stopped discussing 'Forex volatility impacting reported margins' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Alivus Life Sciences Limited
Management stopped discussing 'Capex guidance reduced to ₹450 crore for FY26' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Alivus Life Sciences Limited
Management stopped discussing 'Revenue growth: high single-digit for FY26' — last mentioned in Q3 FY26.
🔇 Silence detected
Q4 FY26
Alkem Laboratories Limited
Management stopped discussing 'FY26 EBITDA margin guidance maintained at ~19.5%' — last mentioned in Q2 FY26.
🔇 Silence detected
Q4 FY26
Alkem Laboratories Limited
Management stopped discussing 'MIP on penicillin derivatives impacting gross margins' — last mentioned in Q3 FY26.